ArticleCureus2025
Epidemiological Profile of Retinopathy of Prematurity in Central India.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRetinopathy of prematurity (ROP) is a vasoproliferative retinal disorder predominantly affecting premature infants with low birth weight. This study aims to investigate the incidence, risk factors, and clinical outcomes of ROP among preterm infants in central India, where the healthcare infrastructure and accessibility vary significantly. MATERIALS AND
methodsThis prospective, observational, non-randomized study was conducted over three years in a tertiary teaching hospital in central India. The study included neonates with a gestational age of less than 34 weeks and/or birth weight of below 2000 grams, as well as neonates between 34 and 36 weeks of gestation who had specific risk factors (e.g., oxygen therapy, sepsis, multiple births, blood transfusion) and were admitted to the neonatal intensive care unit. Infants were screened for ROP, and outcomes were categorized based on the severity of the disease.
resultsOf the 300 preterm infants enrolled, 90 (30%) developed ROP, with 60 (20%) having mild ROP and 30 (10%) requiring treatment for severe ROP. Severe ROP was significantly associated with lower gestational age (mean: 29.8 weeks) and lower birth weight (mean: 1200 grams). Prolonged oxygen therapy, sepsis, multiple pregnancies, and blood transfusions were identified as significant risk factors. Following laser photocoagulation treatment, 85% (n=25) of infants with severe ROP showed regression, though 15% (n=13) experienced complications leading to significant visual impairment.
conclusionThis study emphasizes the importance of comprehensive ROP screening, optimized oxygen therapy guidelines, and robust infection control to mitigate the risk of ROP in central India. Future research should focus on long-term outcomes and innovative prevention and treatment approaches tailored to this population's unique needs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.